Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 12/2004

01-12-2004

Challenging the neuronal MIBG uptake by pharmacological intervention: effect of a single dose of oral amitriptyline on regional cardiac MIBG uptake

Authors: Montserrat Estorch, Ignasi Carrió, Esther Mena, Albert Flotats, Valle Camacho, Jordi Fuertes, Jaume Kulisewsky, Jagat Narula

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 12/2004

Login to get access

Abstract

Purpose

Imaging with metaiodobenzylguanidine (MIBG) is used for the assessment of neuronal dysfunction in various cardiovascular disorders. Although valuable information is obtained by resting MIBG imaging, it is conceivable that competitive interference with the re-uptake mechanism would exaggerate MIBG defects and might unmask subclinical neuronal dysfunction. Tricyclic antidepressants, such as amitriptyline, have been reported to significantly increase cardiac MIBG washout and inhibit uptake into presynaptic neurons. This study was undertaken to assess whether a single oral dose of amitriptyline could influence cardiac MIBG distribution.

Methods

Six patients (aged 62–81 years; four males, two females) who had demonstrated a normal cardiac MIBG scan during work-up for movement disorders were studied. The patients underwent a second 123I-MIBG study after oral administration of 25 mg amitriptyline within 1 week. Single-photon emission computed tomography images were acquired at 4 h to assess the regional distribution of MIBG, after generation of polar maps and employing a 20-segment model. Mean percentage of peak activity was calculated for each segment at rest and after amitriptyline administration.

Results

After amitriptyline administration, there was a decrease in regional MIBG uptake in 10±4 segments per patient [62/120 segments (52%): 37 segments with a 5–10% decrease, 25 segments with a >10% decrease]. This change was statistically significant in lateral (P=0.003), apical (P<0.0001) and inferior (P=0.03) regions.

Conclusion

A single oral dose of amitriptyline can induce changes in the uptake and retention of cardiac MIBG, indicating the feasibility of use of pharmacological intervention in cardiac neurotransmission imaging.
Literature
1.
go back to reference Dae MW, O’Connell J, Botvinick EH, et al. Scintigraphic assessment of regional cardiac innervation. Circulation 1989; 79:634–644. Dae MW, O’Connell J, Botvinick EH, et al. Scintigraphic assessment of regional cardiac innervation. Circulation 1989; 79:634–644.
2.
go back to reference Sisson JC, Wieland DM, Sherman P, Mangner MC, Tobes MC, Jacques S. Metaiodobenzylguanidine as an index of adrenergic nervous system integrity and function. J Nucl Med 1987; 28:1620–1624.PubMed Sisson JC, Wieland DM, Sherman P, Mangner MC, Tobes MC, Jacques S. Metaiodobenzylguanidine as an index of adrenergic nervous system integrity and function. J Nucl Med 1987; 28:1620–1624.PubMed
3.
go back to reference Sisson JC, Bolgos G, Jhonson J. Measuring acute changes in adrenergic nerve activity of the heart in the living animal. Am Heart J 1991; 121:1119–1123.CrossRefPubMed Sisson JC, Bolgos G, Jhonson J. Measuring acute changes in adrenergic nerve activity of the heart in the living animal. Am Heart J 1991; 121:1119–1123.CrossRefPubMed
4.
go back to reference Knickmeier M, Matheja P, Wichter T, et al. Clinical evaluation of no-carrier-added meta-(123I)iodobenzylguanidine for myocardial scintigraphy. Eur J Nucl Med 2000; 3:302–307.CrossRef Knickmeier M, Matheja P, Wichter T, et al. Clinical evaluation of no-carrier-added meta-(123I)iodobenzylguanidine for myocardial scintigraphy. Eur J Nucl Med 2000; 3:302–307.CrossRef
5.
go back to reference Merlet P, Valette H, Dubois-Rande JL, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992; 33:471–477.PubMed Merlet P, Valette H, Dubois-Rande JL, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992; 33:471–477.PubMed
6.
go back to reference Merlet P, Benvenuti C, Moyse D, et al. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med 1999; 40:917–923.PubMed Merlet P, Benvenuti C, Moyse D, et al. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med 1999; 40:917–923.PubMed
7.
go back to reference Maunoury C, Agostini D, Acar P, et al. Impairment of cardiac neuronal function in childhood dilated cardiomyopathy: an I123-MIBG scintigraphic study. J Nucl Med 2000; 41:400–404.PubMed Maunoury C, Agostini D, Acar P, et al. Impairment of cardiac neuronal function in childhood dilated cardiomyopathy: an I123-MIBG scintigraphic study. J Nucl Med 2000; 41:400–404.PubMed
8.
go back to reference Udelson J, Shafer C, Carrió I. Radionuclide imaging in heart failure: assessing etiology and outcomes and implications for management. J Nucl Cardiol 2002; 5:S40–S52.CrossRef Udelson J, Shafer C, Carrió I. Radionuclide imaging in heart failure: assessing etiology and outcomes and implications for management. J Nucl Cardiol 2002; 5:S40–S52.CrossRef
9.
go back to reference Carrio I. Cardiac neurotransmission imaging. J Nucl Med 2001; 42:1062–1076.PubMed Carrio I. Cardiac neurotransmission imaging. J Nucl Med 2001; 42:1062–1076.PubMed
10.
go back to reference Taki J, Nakajima K, Hwang EH, et al. Peripheral sympathetic dysfunction in patients with Parkinson’s disease without autonomic failure is heart selective and disease specific. Eur J Nucl Med 2000; 27:566–573.CrossRefPubMed Taki J, Nakajima K, Hwang EH, et al. Peripheral sympathetic dysfunction in patients with Parkinson’s disease without autonomic failure is heart selective and disease specific. Eur J Nucl Med 2000; 27:566–573.CrossRefPubMed
11.
go back to reference Takatsu H, Nishida H, Matsuo H, et al. Cardiac sympathetic denervation from the early stage of Parkinson’s disease: clinical and experimental studies with radiolabeled MIBG. J Nucl Med 2000; 41:71–77.PubMed Takatsu H, Nishida H, Matsuo H, et al. Cardiac sympathetic denervation from the early stage of Parkinson’s disease: clinical and experimental studies with radiolabeled MIBG. J Nucl Med 2000; 41:71–77.PubMed
12.
go back to reference Yoshita M. Differentiation of idiopathic Parkinson’s disease from striatonogral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy. J Neurol Sci 1998; 155:60–67.CrossRefPubMed Yoshita M. Differentiation of idiopathic Parkinson’s disease from striatonogral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy. J Neurol Sci 1998; 155:60–67.CrossRefPubMed
13.
go back to reference American Society of Nuclear Cardiology. Imaging guidelines for nuclear cardiology procedures, Part 2. J Nucl Cardiol 1999; 6:G47–G84.PubMed American Society of Nuclear Cardiology. Imaging guidelines for nuclear cardiology procedures, Part 2. J Nucl Cardiol 1999; 6:G47–G84.PubMed
14.
go back to reference Charney DS, Menkes DB, Heninger GR. Receptor sensitivity and the mechanism of action of antidepressant treatment. Arch Gen Psychiatry 1981; 38:1160–1180.PubMed Charney DS, Menkes DB, Heninger GR. Receptor sensitivity and the mechanism of action of antidepressant treatment. Arch Gen Psychiatry 1981; 38:1160–1180.PubMed
15.
go back to reference Stahl SM, Grady MM. Differences in mechanism of action between current and future antidepressants. J Clin Psychiatry 2003; 64 Suppl 13:13–17. Stahl SM, Grady MM. Differences in mechanism of action between current and future antidepressants. J Clin Psychiatry 2003; 64 Suppl 13:13–17.
16.
go back to reference Malizia AL, Melichar JK, Rhodes CG, Haida A, Reynolds AH, Jones T, Nutt DJ. Desipramine binding to noradrenaline reuptake sites in cardiac sympathetic neurons in man in vivo. Eur J Pharmacol 2000; 391:263–267.CrossRefPubMed Malizia AL, Melichar JK, Rhodes CG, Haida A, Reynolds AH, Jones T, Nutt DJ. Desipramine binding to noradrenaline reuptake sites in cardiac sympathetic neurons in man in vivo. Eur J Pharmacol 2000; 391:263–267.CrossRefPubMed
17.
go back to reference AHFS (American Hospital Formulary Service). Drug information (1990): antidepressants. In: McEvoy G, ed. AHFS drug information. Bethesda, MD: American Society of Hospital Pharmacists; 1990:1160–1161. AHFS (American Hospital Formulary Service). Drug information (1990): antidepressants. In: McEvoy G, ed. AHFS drug information. Bethesda, MD: American Society of Hospital Pharmacists; 1990:1160–1161.
18.
go back to reference Hollister LE. Tricyclic antidepressants. N Engl J Med 1978; 23:1168–1172. Hollister LE. Tricyclic antidepressants. N Engl J Med 1978; 23:1168–1172.
19.
go back to reference Preskorn SH, Irwin HA. Toxicity of tricyclic antidepressants: kinetics, mechanism, intervention. J Clin Psychiatry 1982; 43:151–156.PubMed Preskorn SH, Irwin HA. Toxicity of tricyclic antidepressants: kinetics, mechanism, intervention. J Clin Psychiatry 1982; 43:151–156.PubMed
20.
go back to reference Stahl SM, Grady MM. Differences in mechanism of action between current and future antidepressants. J Clin Psychiatry 2003; 64 Suppl 13:13–17. Stahl SM, Grady MM. Differences in mechanism of action between current and future antidepressants. J Clin Psychiatry 2003; 64 Suppl 13:13–17.
21.
go back to reference Huangfu D, Goodwin WB, Guyenet PG. Sympatholytic effect of tricyclic antidepressants: site and mechanism of action in anesthetized rats. Am J Physiol 1995; 268:R1429–R1441.PubMed Huangfu D, Goodwin WB, Guyenet PG. Sympatholytic effect of tricyclic antidepressants: site and mechanism of action in anesthetized rats. Am J Physiol 1995; 268:R1429–R1441.PubMed
22.
go back to reference Buckley NA, Chevalier S, Leditschke IA, et al. The limited utility of electrocardiography variables used to predict arrhythmia in psychotropic drug overdose. Crit Care 2003; 5:349–350. Buckley NA, Chevalier S, Leditschke IA, et al. The limited utility of electrocardiography variables used to predict arrhythmia in psychotropic drug overdose. Crit Care 2003; 5:349–350.
23.
go back to reference Perry PJ, Zeilmann C, Arndt S. Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response. J Clin Psychopharmacol 1994; 14:230–240.PubMed Perry PJ, Zeilmann C, Arndt S. Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response. J Clin Psychopharmacol 1994; 14:230–240.PubMed
24.
go back to reference Tsuchimochi S, Tamaki N, Tadamura E, et al. Age and gender differences in normal myocardial adrenergic neuronal function evaluated by iodine-123-MIBG imaging. J Nucl Med 1995; 6:969–974. Tsuchimochi S, Tamaki N, Tadamura E, et al. Age and gender differences in normal myocardial adrenergic neuronal function evaluated by iodine-123-MIBG imaging. J Nucl Med 1995; 6:969–974.
25.
go back to reference Estorch M, Carrió I, Berná Ll, Lopez J, Torres G. Myocardial iodine-labeled metaiodobenzylguanidine uptake relates to age. J Nucl Cardiol 1995; 2:126–132.PubMed Estorch M, Carrió I, Berná Ll, Lopez J, Torres G. Myocardial iodine-labeled metaiodobenzylguanidine uptake relates to age. J Nucl Cardiol 1995; 2:126–132.PubMed
26.
go back to reference Gill JS, Hunter GJ, Gane G, Gamm AJ. Heterogeneity of the human myocardial sympathetic innervation: in vivo demonstration by iodine 123-labeled meta-iodobenzylguanidine scintigraphy. Am Heart J 1993; 2:390–398. Gill JS, Hunter GJ, Gane G, Gamm AJ. Heterogeneity of the human myocardial sympathetic innervation: in vivo demonstration by iodine 123-labeled meta-iodobenzylguanidine scintigraphy. Am Heart J 1993; 2:390–398.
27.
go back to reference Kiyono Y, Iida Y, Kawashima H, et al. Norepinephrine transporter density as a causative factor in alterations in MIBG myocardial uptake in NIDDM model rats. Eur J Nucl Med Mol Imaging 2002; 8:888–1005. Kiyono Y, Iida Y, Kawashima H, et al. Norepinephrine transporter density as a causative factor in alterations in MIBG myocardial uptake in NIDDM model rats. Eur J Nucl Med Mol Imaging 2002; 8:888–1005.
28.
go back to reference Gerson MC, Craft LL, McGuire N, Suresh DP, Abraham WT, Wagoner LE. Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by123I-metaiodobenzylguanidine. J Nucl Cardiol 2002; 9:608–615.CrossRefPubMed Gerson MC, Craft LL, McGuire N, Suresh DP, Abraham WT, Wagoner LE. Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by123I-metaiodobenzylguanidine. J Nucl Cardiol 2002; 9:608–615.CrossRefPubMed
29.
go back to reference Toyama T, Hoshizaki H, Seki R, et al. Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol activity. J Nucl Med 2003; 44:1604–1611.PubMed Toyama T, Hoshizaki H, Seki R, et al. Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol activity. J Nucl Med 2003; 44:1604–1611.PubMed
30.
go back to reference Yamazaki J, Muto H, Kabano T, Yamashina S, Nanjo S, Inoue A. Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy—clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography. Am Heart J 2001; 141:645–652.CrossRefPubMed Yamazaki J, Muto H, Kabano T, Yamashina S, Nanjo S, Inoue A. Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy—clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography. Am Heart J 2001; 141:645–652.CrossRefPubMed
Metadata
Title
Challenging the neuronal MIBG uptake by pharmacological intervention: effect of a single dose of oral amitriptyline on regional cardiac MIBG uptake
Authors
Montserrat Estorch
Ignasi Carrió
Esther Mena
Albert Flotats
Valle Camacho
Jordi Fuertes
Jaume Kulisewsky
Jagat Narula
Publication date
01-12-2004
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 12/2004
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-004-1520-2

Other articles of this Issue 12/2004

European Journal of Nuclear Medicine and Molecular Imaging 12/2004 Go to the issue